Bicycle Therapeutics plc (BCYC) Total liabilities 2018–2025
Bicycle Therapeutics plc (BCYC) total liabilities at each fiscal year-end, per SEC filings.
$107.6MFY2025 · since FY2018: $29.3M → $107.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $107.6M | -34.3% |
| FY2024 | $163.8M | -27.0% |
| FY2023 | $224.4M | +60.5% |
| FY2022 | $139.8M | +4.7% |
| FY2021 | $133.5M | +103.3% |
| FY2020 | $65.7M | +286.5% |
| FY2019 | $17.0M | -41.9% |
| FY2018 | $29.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCYC financial trends
BCYC RevenueBCYC Net incomeBCYC Net marginBCYC Gross profitBCYC Gross marginBCYC Operating incomeBCYC Operating marginBCYC Operating cash flowBCYC Free cash flowBCYC Capital expendituresBCYC Return on equityBCYC Stock buybacksBCYC Dividends paidBCYC Total assetsBCYC Shareholders’ equityBCYC overview →